

Longitudinal Clinical Observations and Motor Coordination Assessments of the SOD1G93A Rat ALS Model
In this live webinar, scientists from Inotiv and Taconic will discuss the impact of the SOD1G93A rat model can make in drug discovery for amyotrophic lateral sclerosis (ALS). Scientists will examine the development of the SOD1 rat model and review the motor phenotypes seen in SOD1G93A rats in a 16-week longitudinal study and their correlation to clinically relevant biomarkers.
Presented by:
Dr. Jessica Ramadhin – Field Applications Scientist, Taconic Biosciences
Dr. Christopher M. Butt – Senior Director-Neuroscience, Inotiv
This live webinar will:
– Discuss the development of a rat model that expresses human SOD1 with the G93A mutation and why the G93A mutation is relevant to ALS
– Explore the disease phenotype of the SOD1G93A rat model
– Provide insight into how variability in disease phenotype of the SOD1G93A rat model is addressed in study planning